Drug Shortage Report for ALPROLIX

Last updated on 2023-01-31 History
Report ID 180122
Drug Identification Number 02422956
Brand name ALPROLIX
Common or Proper name ALPROLIX 3000
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN
Strength(s) 3000UNIT
Dosage form(s) POWDER FOR SOLUTION KIT
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 3000 IU/vial
ATC code B02BD
ATC description VITAMIN K AND OTHER HEMOSTATICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-01-05
Estimated end date 2023-01-31
Actual end date 2023-01-30
Shortage status Resolved
Updated date 2023-01-31
Company comments
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2023-01-31 English Compare
v4 2023-01-30 French Compare
v3 2023-01-30 English Compare
v2 2023-01-06 French Compare
v1 2023-01-06 English Compare

Showing 1 to 5 of 5